SKYE BIOSCIENCE : AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS - Form 8-K -April 03, 2024 at 05:11 pm EDT
SKYE BIOSCIENCE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS ...
Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SKYE BIOSCIENCE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS ...
Financing expected to fund strategic expansion of obesity clinical development and extend operating runway beyond 2026San Diego, California--(News...
Piper Sandler assumed coverage on shares of Skye Bioscience (OTCMKTS:SKYE – Free Report) in a research report released on Monday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $12.00 price target on the stock. Skye Bioscience Stock Performance OTCMKTS:SKYE opened at $4.90 on Monday. The firm has a market capitalization of $60.52 […]
Skye Bioscience, Inc. , a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid...
Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report)’s stock price shot up 8.6% on Friday . The company traded as high as $4.04 and last traded at $4.01. 4,485 shares changed hands during trading, a decline of 0% from the average session volume of 4,486 shares. The stock had previously closed at $3.69. Skye Bioscience […]